Julia Carbonetti

Counsel

Overview

Julia Carbonetti is a counsel in the firm’s Washington, D.C. office, where she practices in the Mass Torts, Product, and Consumer Litigation Group.

Julia represents clients in complex tort and product liability matters, with a particular focus on the transportation industry. She handles all aspects of litigation, including dispositive motions, mediations, and/or arbitrations. She also has experience defending clients in breach of warranty and negligence cases.

Julia served as a law clerk to the Honorable Joseph M. Getty, Court of Appeals of Maryland, and as a judicial law clerk to the Honorable Fred S. Hecker, Circuit Court for Carroll County, Maryland. She was the Notes & Comments Editor of the Journal of Business and Technology while in law school.

Career & Education

|
    • University of Maryland, College Park, B.A., 2013
    • University of Maryland School of Law, J.D., cum laude, 2016
    • University of Maryland, College Park, B.A., 2013
    • University of Maryland School of Law, J.D., cum laude, 2016
    • Maryland
    • District of Columbia
    • U.S. District Court for the District of Maryland
    • U.S. District Court for the District of Columbia
    • Maryland
    • District of Columbia
    • U.S. District Court for the District of Maryland
    • U.S. District Court for the District of Columbia

Julia's Insights

Client Alert | 3 min read | 03.27.25

MoCRA Under the Trump Era: A Look at FDA's Monitoring and Enforcement Two Months In

Despite other sweeping changes to the federal government under the Trump administration, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), passed under former President Biden, remains good law. Below, we report on recent trends in FDA’s implementation and enforcement of MoCRA in the early months of Trump’s presidency....

|

Julia's Insights

Client Alert | 3 min read | 03.27.25

MoCRA Under the Trump Era: A Look at FDA's Monitoring and Enforcement Two Months In

Despite other sweeping changes to the federal government under the Trump administration, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), passed under former President Biden, remains good law. Below, we report on recent trends in FDA’s implementation and enforcement of MoCRA in the early months of Trump’s presidency....